BigHat Biosciences

Imagine a 3D surface with peaks and valleys of complex shapes. Then expand that surface into many more than three dimens...

a16zActive

What they do

Problem

Designing antibody medicines that satisfy many simultaneous requirements (affinity, developability, safety, etc.) is slow, expensive, and difficult with traditional methods.

Solution

BigHat Biosciences uses high-dimensional machine learning and experimental data generation to design and optimize therapeutic antibodies across multiple properties.

Who it's for

Biopharma companies and drug discovery teams developing antibody therapeutics.